Warby Parker Inc (WRBY) Return on Investment ROI from the second quarter of 2026 to second quarter of 2025 and for the year 2026, average high and low, overall ranking from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Warby Parker Inc   (NYSE: WRBY)


Warby Parker Inc's ROI from its second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Warby Parker Inc's ROI in the second quarter of 2026?
Warby Parker Inc achieved a return on average invested assets (ROI) of 1.32 % in its second quarter of 2026, which is below Warby Parker Inc's average return on investment, which stands at 5.61%.

ROI has improved compared to 0.23% in the first quarter of 2026, due to net income growth.

Within the Healthcare sector 142 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the first quarter of 2026 from 1608 to 2468.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Investment Change TTM 29.49 % 46.24 % 71.27 % 58.49 % 43.63 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 609 583 571 575 566
Return On Investment (TTM) 1.32 % 0.23 % 0.29 % 0.14 % -2.04 %
WRBY's Overall Ranking # 2468 # 1608 # 2235 # 2336 # 2185
Seq. Investment Change TTM 1.85 % 1.01 % 11.25 % 13.13 % 15.03 %
Seq. Net Income Change TTM 475.19 % -17.98 % 128.87 % - -
Net Income (TTM) in Millions 8 1 2 1 -9

WRBY Company Profile >> Back to WRBY Roi Comparisons >> See Annual WRBY Return On Investment



Return On Investment WRBY's Ranking
Within: No.
Industry # 48
Sector # 143
Overall # 2468

Return On Investment Statistics
High Average Low
347.11 %
5.61 %
-112.02 %
(Dec 31 2021)   (Sep 30 2021)







Financial Statements
Warby Parker Inc's II. Quarter Investments $ 609 Millions WRBY's Balance sheet
Warby Parker Inc's II. Quarter Income $ 5 Millions Quarterly WRBY's Income Statement
WRBY's Income by Division See WRBY's Income by Division


WRBY Annual Return On Investment (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021
Total Investments in Millions 369 341 303 288 323
Y / Y Investment Growth 8.22 % 12.53 % 5.11 % -10.61 % -
Net Income in Millions 2 -20 -63 -110 -144
Y / Y Net Income Growth - - - - -
Annual Return On Investment 0.44 % -5.98 % -20.85 % -38.29 % -44.73 %


Annual Roi Comment
In the fiscal year 2025 ROI improved to 0.44 % compared to the prior year, due to net income growth.

Definition and Formula of Return on Investment

Other ROI Ratios
Medical Equipment & Supplies Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
WRBY's Roi Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for WRBY's Competitors
Subscribers only: Roi for Warby Parker Inc's Suppliers
Subscribers only: Return On Investment for WRBY's Customers

Other Ratios
WRBY's Roa WRBY's Inventory Turnover Ratio WRBY's Growth Rates WRBY's Dividend Statistics
WRBY's Profitability Ratios WRBY's Asset Turnover Ratio WRBY's Dividend Growth
WRBY's Roe WRBY's Valuation Ratios WRBY's Financial Strength Ratios WRBY's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector ROI
Merck and Co Inc   3.24 %
Community Health Systems Inc   3.12 %
National Vision Holdings Inc   2.99 %
Teva Pharmaceutical Industries Limited  2.66 %
Lifestance Health Group Inc   2.61 %
Conmed Corporation  2.57 %
Pfizer Inc  2.53 %
Mimedx Group Inc   2.38 %
Bio rad Laboratories Inc   2.34 %
Lifemd Inc   2.32 %
Alkermes Plc   2.31 %
Becton Dickinson And Company  2.22 %
Revvity Inc  2.18 %
Envista Holdings Corporation  2.06 %
Immucell Corporation  1.95 %
Atricure Inc   1.84 %
Black Hawk Acquisition Corporation  1.79 %
Omada Health Inc   1.70 %
Arvinas Inc   1.53 %
Repligen Corp  1.41 %
Cormedix Inc   1.31 %
Pacira Biosciences inc   1.29 %
Waters Corporation  1.20 %
Surgery Partners Inc   1.02 %
Warby Parker Inc   0.98 %
Staar Surgical Co  0.98 %
Biomarin Pharmaceutical Inc  0.91 %
Icu Medical Inc  0.87 %
Radnet Inc   0.45 %
Delcath Systems Inc   0.45 %

Date modified: 2026-09-08T21:54:07+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.